Fraser Dove International

👇 𝐓𝐡𝐞𝐬𝐞 𝐀𝐫𝐞 𝐘𝐨𝐮𝐫 𝐓𝐨𝐩 𝟓 𝐍𝐞𝐰𝐬 𝐒𝐭𝐨𝐫𝐢𝐞𝐬 𝐀𝐫𝐨𝐮𝐧𝐝 𝐅𝐢𝐧𝐚𝐧𝐜𝐢𝐚𝐥 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭𝐬 𝐘𝐨𝐮 𝐍𝐞𝐞𝐝 𝐭𝐨 𝐑𝐞𝐚𝐝 𝐓𝐡𝐢𝐬 𝐖𝐞𝐞𝐤 👇 1️⃣ Repair Biotechnologies and Genevant Sciences have entered a collaboration to develop mRNA therapies targeting cholesterol build-up in arteries (atherosclerosis). Repair will utilise Genevant's lipid nanoparticle delivery technology to transport cholesterol-degrading mRNA. The deal could result in Genevant receiving up to $107 million per product and tiered royalties. 📰 https://lnkd.in/e8JPSYnv 2️⃣ CSL Seqirus has secured a $121.4 million contract from BARDA to increase the U.S.' stockpile of its MF59 adjuvant, boosting pandemic preparedness for avian influenza. The company will manufacture the adjuvant at its North Carolina facility, expanding reserves to cover 40 million vaccine doses. 📰 https://lnkd.in/eN_Cd6rX 3️⃣ Europlaz, a contract manufacturing specialist, reports a 20% year-on-year sales growth after a £3.5 million investment over three years. The company expanded its capacity by acquiring electric injection moulding machines, upgrading robotics, and enhancing cleanroom facilities, primarily to serve the medical device sector. 📰 https://lnkd.in/eZUamZFy 4️⃣ Mendaera has secured $73 million in Series B funding to advance its handheld robotics platform, designed for needle-based procedures such as biopsies and pain management. The technology combines real-time imaging with robotic guidance to address healthcare provider shortages and increase access to high-quality care. 📰 https://lnkd.in/evQNRhaw 5️⃣ SK pharmteco is investing $260 million to expand its small molecule and peptide production capabilities in Sejong, South Korea. The new facility, expected to be operational by late 2026, will include eight production lines, supporting the increasing demand for peptides and small molecules used in innovative therapies. 📰 https://lnkd.in/eQ63p8j2 #FinancialDevelopments | #LifeSciences | #NewsRoundUp

1️⃣ 𝐀𝐫𝐞 𝐲𝐨𝐮 𝐚𝐧 𝐞𝐱𝐩𝐞𝐫𝐭 𝐢𝐧 𝐩𝐫𝐨𝐜𝐞𝐬𝐬 𝐜𝐡𝐞𝐦𝐢𝐬𝐭𝐫𝐲 𝐫𝐞𝐚𝐝𝐲 𝐭𝐨 𝐬𝐡𝐚𝐩𝐞 𝐭𝐡𝐞 𝐟𝐮𝐭𝐮𝐫𝐞 𝐨𝐟 𝐩𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥 𝐦𝐚𝐧𝐮𝐟𝐚𝐜𝐭𝐮𝐫𝐢𝐧𝐠? 2️⃣ 𝐃𝐨 𝐲𝐨𝐮 𝐡𝐚𝐯𝐞 𝐚 𝐬𝐭𝐫𝐨𝐧𝐠 𝐭𝐫𝐚𝐜𝐤 𝐫𝐞𝐜𝐨𝐫𝐝 𝐢𝐧 𝐝𝐫𝐢𝐯𝐢𝐧𝐠 𝐩𝐫𝐨𝐜𝐞𝐬𝐬 𝐝𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭 𝐚𝐧𝐝 𝐞𝐱𝐞𝐜𝐮𝐭𝐢𝐧𝐠 𝐬𝐮𝐜𝐜𝐞𝐬𝐬𝐟𝐮𝐥 𝐭𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲 𝐭𝐫𝐚𝐧𝐬𝐟𝐞𝐫𝐬? 3️⃣ 𝐂𝐚𝐧 𝐲𝐨𝐮 𝐥𝐞𝐚𝐝 𝐭𝐞𝐚𝐦𝐬 𝐢𝐧 𝐚 𝐟𝐚𝐬𝐭-𝐩𝐚𝐜𝐞𝐝 𝐞𝐧𝐯𝐢𝐫𝐨𝐧𝐦𝐞𝐧𝐭, 𝐛𝐚𝐥𝐚𝐧𝐜𝐢𝐧𝐠 𝐡𝐢𝐠𝐡 𝐞𝐱𝐩𝐞𝐜𝐭𝐚𝐭𝐢𝐨𝐧𝐬 𝐰𝐢𝐭𝐡 𝐢𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧 𝐚𝐧𝐝 𝐩𝐫𝐞𝐜𝐢𝐬𝐢𝐨𝐧? ✅ Tick, tick and tick, this role may be the perfect fit! ✅ Fraser Dove International is working exclusively with a leading pharmaceutical organisation dedicated to advancing pharmaceutical manufacturing and API development. As 𝐃𝐢𝐫𝐞𝐜𝐭𝐨𝐫 𝐏𝐫𝐨𝐜𝐞𝐬𝐬 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭, you will be responsible for providing process chemistry expertise to support CDMO business operations and leading and managing process chemistry activities in the Advanced Manufacturing R&D lab. 𝐆𝐨𝐭 𝐰𝐡𝐚𝐭 𝐢𝐭 𝐭𝐚𝐤𝐞𝐬? 𝐀𝐩𝐩𝐥𝐲 𝐭𝐨𝐝𝐚𝐲 𝐯𝐢𝐚 𝐭𝐡𝐞 𝐥𝐢𝐧𝐤 𝐛𝐞𝐥𝐨𝐰 👇 https://lnkd.in/e8cNsU46 Alternatively, contact Allec Romero for more information on this and similar opportunities with life science organisations in America, Asia, and Europe. #DirectorProcessDevelopment | #LifeSciences | #FraserDove | #RoleOfTheWeek

“𝐇𝐞 𝐰𝐚𝐬 𝐞𝐱𝐭𝐫𝐞𝐦𝐞𝐥𝐲 𝐩𝐫𝐨𝐟𝐞𝐬𝐬𝐢𝐨𝐧𝐚𝐥 𝐚𝐧𝐝 𝐫𝐞𝐬𝐩𝐨𝐧𝐬𝐢𝐯𝐞 𝐝𝐮𝐫𝐢𝐧𝐠 𝐭𝐡𝐞 𝐡𝐢𝐫𝐢𝐧𝐠 𝐩𝐫𝐨𝐜𝐞𝐬𝐬”. ✅ Communication is key ✅ Keep putting smiles on our candidate’s faces team! 😊 #ExecutiveSearch | #LifeSciences | #FraserDove | #Testimonial

🚨 𝐍𝐞𝐰 𝐄𝐩𝐢𝐬𝐨𝐝𝐞 𝐀𝐥𝐞𝐫𝐭 🚨 Hosted by our Global Head of MedTech, Iain McCulley, we speak to professionals within MedTech, with the aim to add value through insights from inside the industry. With these conversations, we hope to help individuals and organisations overcome some of the biggest challenges in the industry right now. This episode is a part of our Start-Up Spotlight Series, where we shine a light on some of the most innovative and exciting start-ups in MedTech. In this episode we speak to Venk Varadan, Co-Founder & CEO at Nanowear. Venk shares his journey from academia and finance to leading a groundbreaking startup in the MedTech industry. Nanowear’s unique cloth-based nanotechnology is poised to revolutionise at-home diagnostics, offering a non-invasive way to monitor cardiovascular and pulmonary health. Have a listen to discover more about: 👉 𝐓𝐡𝐞 𝐢𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧 𝐨𝐟 𝐍𝐚𝐧𝐨𝐰𝐞𝐚𝐫 👉 𝐕𝐞𝐧𝐤’𝐬 𝐜𝐚𝐫𝐞𝐞𝐫 𝐣𝐨𝐮𝐫𝐧𝐞𝐲 👉 𝐓𝐫𝐚𝐧𝐬𝐩𝐚𝐫𝐞𝐧𝐜𝐲 𝐢𝐧 𝐥𝐞𝐚𝐝𝐞𝐫𝐬𝐡𝐢𝐩 Have a listen to the full episode below 👇 https://lnkd.in/e3mqrNFm

❌ 𝐈𝐧𝐯𝐞𝐬𝐭𝐢𝐧𝐠 𝐡𝐞𝐚𝐯𝐢𝐥𝐲 𝐢𝐧 𝐞𝐦𝐩𝐥𝐨𝐲𝐞𝐫 𝐛𝐫𝐚𝐧𝐝𝐢𝐧𝐠 𝐛𝐮𝐭 𝐧𝐨𝐭 𝐬𝐞𝐞𝐢𝐧𝐠 𝐭𝐡𝐞 𝐫𝐞𝐬𝐮𝐥𝐭𝐬 𝐲𝐨𝐮 𝐞𝐱𝐩𝐞𝐜𝐭𝐞𝐝? ❌ If you're not leveraging the authentic voices of your leaders, you're not appealing to leaders. Period. Today, senior-level candidates are increasingly choosing leaders over companies. Placing your leaders at the forefront of your employer branding efforts is pivotal to success 🌟 Our expert eGuide, tailored for C-Suite and HR professionals in the life sciences, offers in-depth strategies for building a robust Digital Hiring Identity around your leadership that hooks A-players. 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐨𝐮𝐫 𝐞𝐆𝐮𝐢𝐝𝐞 𝐭𝐨𝐝𝐚𝐲 𝐚𝐧𝐝 𝐬𝐭𝐚𝐫𝐭 𝐚𝐭𝐭𝐫𝐚𝐜𝐭𝐢𝐧𝐠 𝐭𝐡𝐞 𝐥𝐞𝐚𝐝𝐞𝐫𝐬 𝐰𝐡𝐨 𝐰𝐢𝐥𝐥 𝐝𝐫𝐢𝐯𝐞 𝐲𝐨𝐮𝐫 𝐜𝐨𝐦𝐩𝐚𝐧𝐲'𝐬 𝐬𝐮𝐜𝐜𝐞𝐬𝐬! 👇 https://lnkd.in/e4xbbWYd #AttractTalent | #FreeEGuide | #ExecutiveSearch | #Resources

1️⃣ 𝐀𝐫𝐞 𝐲𝐨𝐮 𝐫𝐞𝐚𝐝𝐲 𝐭𝐨 𝐝𝐫𝐢𝐯𝐞 𝐜𝐨𝐦𝐩𝐥𝐢𝐚𝐧𝐜𝐞 𝐚𝐧𝐝 𝐨𝐩𝐞𝐫𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐞𝐱𝐜𝐞𝐥𝐥𝐞𝐧𝐜𝐞 𝐢𝐧 𝐚 𝐟𝐚𝐬𝐭-𝐩𝐚𝐜𝐞𝐝 𝐦𝐚𝐧𝐮𝐟𝐚𝐜𝐭𝐮𝐫𝐢𝐧𝐠 𝐞𝐧𝐯𝐢𝐫𝐨𝐧𝐦𝐞𝐧𝐭? 2️⃣ 𝐃𝐨 𝐲𝐨𝐮 𝐡𝐚𝐯𝐞 𝐚 𝐩𝐚𝐬𝐬𝐢𝐨𝐧 𝐟𝐨𝐫 𝐥𝐞𝐚𝐝𝐢𝐧𝐠 𝐜𝐨𝐧𝐭𝐢𝐧𝐮𝐨𝐮𝐬 𝐢𝐦𝐩𝐫𝐨𝐯𝐞𝐦𝐞𝐧𝐭 𝐢𝐧𝐢𝐭𝐢𝐚𝐭𝐢𝐯𝐞𝐬 𝐚𝐧𝐝 𝐝𝐫𝐢𝐯𝐢𝐧𝐠 𝐭𝐫𝐚𝐧𝐬𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧? 3️⃣ 𝐀𝐫𝐞 𝐲𝐨𝐮 𝐞𝐱𝐜𝐢𝐭𝐞𝐝 𝐭𝐨 𝐟𝐨𝐬𝐭𝐞𝐫 𝐚 𝐜𝐮𝐥𝐭𝐮𝐫𝐞 𝐨𝐟 "𝐐𝐮𝐚𝐥𝐢𝐭𝐲 𝐅𝐢𝐫𝐬𝐭" 𝐰𝐡𝐢𝐥𝐞 𝐝𝐞𝐯𝐞𝐥𝐨𝐩𝐢𝐧𝐠 𝐭𝐡𝐞 𝐧𝐞𝐱𝐭 𝐠𝐞𝐧𝐞𝐫𝐚𝐭𝐢𝐨𝐧 𝐨𝐟 𝐪𝐮𝐚𝐥𝐢𝐭𝐲 𝐩𝐫𝐨𝐟𝐞𝐬𝐬𝐢𝐨𝐧𝐚𝐥𝐬? ✅ 3 out of 3? This role could be a great fit! ✅ Fraser Dove International is partnering exclusively with a global Consumer Health organisation. Operating across the globe, they are committed to delivering high-quality products while ensuring regulatory compliance and leading innovation. As 𝐇𝐞𝐚𝐝 𝐨𝐟 𝐐𝐮𝐚𝐥𝐢𝐭𝐲, you will be responsible for overseeing quality management and compliance efforts across manufacturing and supply chain operations. 👇 𝐅𝐢𝐭 𝐭𝐡𝐞 𝐛𝐢𝐥𝐥? 𝐀𝐩𝐩𝐥𝐲 𝐭𝐨𝐝𝐚𝐲 𝐯𝐢𝐚 𝐭𝐡𝐞 𝐥𝐢𝐧𝐤 𝐛𝐞𝐥𝐨𝐰 👇 https://lnkd.in/eMKnmBr4 Alternatively, contact Aidan Russell for more information on this and similar opportunities with life science organisations in America, Asia, and Europe. #HeadOfQuality #LifeSciences #FraserDove #RoleOfTheWeek

“𝐓𝐡𝐞 𝐅𝐃𝐈 𝐭𝐞𝐚𝐦 𝐰𝐞𝐫𝐞 𝐝𝐢𝐥𝐢𝐠𝐞𝐧𝐭, 𝐨𝐫𝐠𝐚𝐧𝐢𝐬𝐞𝐝, 𝐚𝐧𝐝 𝐰𝐞𝐧𝐭 𝐭𝐡𝐞 𝐞𝐱𝐭𝐫𝐚 𝐦𝐢𝐥𝐞 𝐭𝐨 𝐟𝐢𝐧𝐝 𝐪𝐮𝐚𝐥𝐢𝐭𝐲 𝐜𝐚𝐧𝐝𝐢𝐝𝐚𝐭𝐞𝐬”. ✅ Giving our clients 110 once again ✅ Keep up the good work team! 👏 #Testimonial | #ExecutiveSearch | #LifeSciences | #FraserDove

🚨 𝐈𝐧𝐭𝐫𝐨𝐝𝐮𝐜𝐢𝐧𝐠 𝐈𝐧𝐬𝐢𝐝𝐞 𝐌𝐞𝐝𝐓𝐞𝐜𝐡 🚨 Hosted by our Global Head of MedTech, Iain McCulley, we speak to professionals within MedTech, with the aim to add value through insights from inside the industry. During these free live broadcasts, we hope to help individuals and organisations overcome some of the biggest challenges in the industry. This episode is a part of our Start-Up Spotlight Series, where we shine a light on some of the most innovative and exciting start-ups in MedTech. In this episode we speak to Joseph Bentley, Founder and Managing Director at ACT Medical. Joseph shares his inspiring journey from university student to entrepreneur, driven by a personal experience that highlighted the global challenge of knife crime. Tune in to learn more about: 👉 𝐉𝐨𝐬𝐞𝐩𝐡’𝐬 𝐁𝐚𝐜𝐤𝐠𝐫𝐨𝐮𝐧𝐝 𝐚𝐧𝐝 𝐌𝐨𝐭𝐢𝐯𝐚𝐭𝐢𝐨𝐧 👉 𝐓𝐡𝐞 𝐝𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭 𝐨𝐟 𝐀𝐜𝐭 𝐌𝐞𝐝𝐢𝐜𝐚𝐥’𝐬 𝐅𝐢𝐫𝐬𝐭 𝐏𝐫𝐨𝐝𝐮𝐜𝐭 👉 𝐓𝐡𝐞 𝐢𝐦𝐩𝐨𝐫𝐭𝐚𝐧𝐜𝐞 𝐨𝐟 𝐄𝐧𝐠𝐚𝐠𝐢𝐧𝐠 𝐄𝐧𝐝-𝐔𝐬𝐞𝐫𝐬 Have a listen to the full episode below 👇 https://lnkd.in/emn6cUSe #IndustryInsights | #InsideMedTech | #TuneIn

🧠 𝐓𝐨𝐝𝐚𝐲 𝐢𝐬 𝐖𝐨𝐫𝐥𝐝 𝐀𝐥𝐳𝐡𝐞𝐢𝐦𝐞𝐫’𝐬 𝐃𝐚𝐲 🧠   At Fraser Dove, we’d like to reflect on the strides the life sciences has made in understanding and developing treatments for Alzheimer's. Treatments like Acetylcholinesterase (AChE) inhibitors, Memantine, and Cognitive stimulation therapy. We’d also like to highlight the challenges that still lay ahead in our fight against Alzheimer’s, crucially, finding a cure.   In life sciences, we have the power to push boundaries, explore new therapies, and bring hope to millions.   🌟 𝐋𝐞𝐭'𝐬 𝐤𝐞𝐞𝐩 𝐢𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐧𝐠 𝐟𝐨𝐫 𝐚 𝐟𝐮𝐭𝐮𝐫𝐞 𝐰𝐢𝐭𝐡𝐨𝐮𝐭 𝐀𝐥𝐳𝐡𝐞𝐢𝐦𝐞𝐫'𝐬 🌟   #WorldAlzheimersDay | #AlzheimersAwareness | #LifeSciences

👇 𝐓𝐡𝐞𝐬𝐞 𝐀𝐫𝐞 𝐘𝐨𝐮𝐫 𝐓𝐨𝐩 𝟓 𝐍𝐞𝐰𝐬 𝐒𝐭𝐨𝐫𝐢𝐞𝐬 𝐀𝐫𝐨𝐮𝐧𝐝 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐁𝐫𝐞𝐚𝐤𝐭𝐡𝐫𝐨𝐮𝐠𝐡𝐬 𝐘𝐨𝐮 𝐍𝐞𝐞𝐝 𝐭𝐨 𝐑𝐞𝐚𝐝 𝐓𝐡𝐢𝐬 𝐖𝐞𝐞𝐤 👇 1️⃣ Ichnos Sciences and Glenmark Pharmaceuticals have developed a trispecific antibody, ISB 2001, which significantly outperforms existing treatments like Tecvayli and alnuctamab in treating multiple myeloma in both human cell lines and mouse models. It is currently in a phase 1 clinical trial. 📰 https://lnkd.in/ehj9qNPh 2️⃣ Daiichi Sankyo and Merck's antibody-drug conjugate (ADC), patritumab deruxtecan, successfully delayed tumour progression in a Phase 3 trial for patients with non-small cell lung cancer (NSCLC) featuring an EGFR mutation. Despite a previous FDA rejection due to manufacturing issues, this data strengthens the case for approval. 📰 https://lnkd.in/gdT388dH 3️⃣ Hoth Therapeutics' drug candidate, HT-ALZ, derived from the anti-nausea agent aprepitant, shows promise in reducing Alzheimer's disease progression. It lowers reactive astrocyte activity in the hippocampus and cortex, which are early targets in Alzheimer's, leading to improved cognitive function in mice. 📰 https://lnkd.in/ebHR7PNY 4️⃣ Ossium Health has treated its first leukaemia patient using cryopreserved bone marrow from deceased organ donors as part of its PRESERVE I clinical trial. This approach aims to provide a faster and more accessible alternative to traditional bone marrow transplants, which often face donor availability issues. 📰 https://lnkd.in/e5B6a2vG 5️⃣ Innovent Biologics presented promising Phase 1 trial data for IBI363, a checkpoint inhibitor-cytokine fusion protein, combined with Avastin. The trial showed a 21.9% response rate in advanced colorectal cancer patients, including those with liver metastases and prior immunotherapy. 📰 https://lnkd.in/egVaAcMZ #ResearchBreakthroughs | #LifeSciences | #NewsRoundUp